Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 7/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 1.00 |
| ▸ | MEN1 | O00255 | 6/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 6/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 6/20 | 1.00 |
| ▸ | MAPT | P10636 | 5/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 4/20 | 1.00 |
| ▸ | HPGD | P15428 | 4/20 | 1.00 |
| ▸ | HIF1A | Q16665 | 3/20 | 1.00 |
| ▸ | USP2 | O75604 | 2/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 2/20 | 1.00 |
| ▸ | GAA | P10253 | 1/20 | 1.00 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 1.00 |
| ▸ | RECQL | P46063 | 3/20 | 0.66 |
| ▸ | PLEC | Q15149 | 1/20 | 0.66 |
| ▸ | DRD3 | P35462 | 7/20 | 0.64 |
| ▸ | DRD2 | P14416 | 6/20 | 0.64 |
| ▸ | HTR2B | P41595 | 6/20 | 0.64 |
| ▸ | HTR6 | P50406 | 6/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14029480 | 1.00 | HSD17B10 (1.00) | HSD17B10KDM4EALDH1A1MEN1KMT2A | |
| SCHEMBL30278505 | 1.00 | HSD17B10 (1.00) | HSD17B10KDM4EALDH1A1MEN1KMT2A | |
| SCHEMBL10471429 | 1.00 | HSD17B10 (1.00) | HSD17B10KDM4EALDH1A1MEN1KMT2A | |
| SCHEMBL25042463 | 1.00 | HSD17B10 (1.00) | HSD17B10KDM4EALDH1A1MEN1KMT2A | |
| SCHEMBL7176983 | 1.00 | HSD17B10 (1.00) | HSD17B10KDM4EALDH1A1MEN1KMT2A | |
| SCHEMBL25042462 | 1.00 | HSD17B10 (1.00) | HSD17B10KDM4EALDH1A1MEN1KMT2A | |
| SCHEMBL9820435 | 1.00 | HSD17B10 (1.00) | HSD17B10KDM4EALDH1A1MEN1KMT2A | |
| SCHEMBL25042461 | 1.00 | HSD17B10 (1.00) | HSD17B10KDM4EALDH1A1MEN1KMT2A | |
| SCHEMBL257961 | 1.00 | HSD17B10 (1.00) | HSD17B10KDM4EALDH1A1MEN1KMT2A | |
| Methyl Alcohol SCHEMBL27814674 | 0.99 | HSD17B10 (0.98) | HSD17B10KDM4EALDH1A1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 681 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026043908-A1 | COMPOSITIONS AND METHODS TO IMPROVE SEQUESTRATION OF MYCOTOXINS AND THEIR USE IN DETOXIFICATION OF ANIMAL FEED AND ANIMAL PRODUCTION SYSTEMS | ALLTECH, INC. (US) | 2026-02-26 | — | — | WO | claimed |
| EP-4674894-A2 | COPOLYMERS OF N-VINYLPYRROLIDONE WITH FUNCTIONALIZED MALEIC ACID MOIETIES | Hemoteq AG (DE) | 2026-01-07 | — | — | EP | claimed |
| EP-4663688-A2 | CROSSLINKERS | Hemoteq AG (DE) | 2025-12-17 | — | — | EP | claimed |
| EP-4401713-A1 | ALIMENTARY-RELATED PARTICLES, PRODUCTION METHODS, AND PRODUCTION APPARATUS | Nulixir Inc. (US) | 2024-07-24 | — | — | EP | claimed |
| EP-4401711-A1 | STABLE NON-AQUEOUS COMPOSITIONS OF FUNCTIONAL INGREDIENTS AND METHODS OF MAKING THE SAME | Nulixir Inc. (US) | 2024-07-24 | — | — | EP | claimed |
| EP-4401714-A1 | ORAL COMPOSITIONS WITH PLANT MATTER EXTRACTS AND METHODS OF MAKING THE SAME | Nulixir Inc. (US) | 2024-07-24 | — | — | EP | claimed |
| US-11964049-B2 | Water soluble compositions and methods of making the same | Nulixir Inc. (US) | 2024-04-23 | — | — | US | claimed |
| US-20240041792-A1 | TOPICAL COMPOSITIONS AND USES THEREOF | TRUETIVA, Inc. (US) | 2024-02-08 | — | — | US | claimed |
| WO-2024023715-A1 | TOPICAL COMPOSITIONS AND USES THEREOF | Truetiva Inc. (US) | 2024-02-01 | — | — | WO | claimed |
| US-20230277477-A1 | COMPOSITIONS FOR TREATING DERMATOLOGICAL DISEASES | TRUETIVA, Inc. (US) | 2023-09-07 | — | — | US | claimed |
| EP-0156645-B1 | PROCESS FOR THE PREPARATION OF N1-METHYL-10ALPHA-METHOXYLUMILYSERGOL AND ESTERS THEREOF, AND INTERMEDIATES FOR THEIR PREPARATION | INVERNI DELLA BEFFA S.P.A. (IT) | 1989-11-02 | — | — | EP | claimed |
| EP-0171988-B1 | A PROCESS FOR PREPARING LYSERGOL DERIVATIVES | INVERNI DELLA BEFFA S.P.A. (IT) | 1989-06-21 | — | — | EP | claimed |
| EP-0251652-A2 | t-Butyl ergoline derivatives | FARMITALIA CARLO ERBA S.r.l. (IT) | 1988-01-07 | — | — | EP | claimed |
| EP-0209456-A1 | Process for the preparation of N-methyl lysergol | RHONE-POULENC SANTE (FR) | 1987-01-21 | — | — | EP | claimed |
| CN-86104086-A | The preparation method of 2-halogen nicergoline derivatives and its acid salt and new 2-halogen Varson class | — | 1986-12-17 | — | — | CN | claimed |
| EP-0171988-A2 | A process for preparing lysergol derivatives | INVERNI DELLA BEFFA S.P.A. (IT) | 1986-02-19 | — | — | EP | claimed |
| EP-0004664-B1 | A PROCESS FOR PREPARING LYSERGOL DERIVATIVES | Corvi Mora, Enrico (IT) | 1982-04-14 | — | — | EP | claimed |
| US-4232157-A | Process for preparing lysergol derivatives | ISTITUTO CHEMIOTERAPICO DI LODI SPA, A CORP OF ITALY (IT) | 1980-11-04 | — | — | US | claimed |
| US-4198344-A | Process for the preparation of polyhydroxylated steroids, lysergol and ergolinic alkaloids | SIMES SOCIETA ITALIANA MEDICINALI E SINTETICI S.P.A. (IT) | 1980-04-15 | — | — | US | claimed |
| EP-0004664-A1 | A process for preparing lysergol derivatives | Corvi Mora, Enrico (IT) | 1979-10-17 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230277477-A1 | COMPOSITIONS FOR TREATING DERMATOLOGICAL DISEASES | CNR2, CNR1, FAAH | HSD17B10 1138/4885KDM4E 1425/4885ALDH1A1 3832/4885 |
| US-20240041792-A1 | TOPICAL COMPOSITIONS AND USES THEREOF | COL14A1, COL2A1, COL1A1 | HSD17B10 2780/4885KDM4E 2436/4885ALDH1A1 3241/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.